A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis

Gastroenterology

Volumn 146, Issue 5, 2014, Pages

  El Serag, Hashem B ^a,b,c   Kanwal, Fasiha ^a,b,c   Davila, Jessica A ^a,b,c   Kramer, Jennifer ^a,b,c   Richardson, Peter ^a,b,c  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Keywords; Liver Cancer; Prediction; Prognosis; Risk Factors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN;

ACCURACY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALGORITHM; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER RISK; CREATININE BLOOD LEVEL; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LABORATORY; LABORATORY BASED ALGORITHM; LEUKOCYTE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE; THROMBOCYTE COUNT;

LIVER CANCER; PREDICTION; PROGNOSIS; RISK FACTORS;

AGE FACTORS; AGED; ALANINE TRANSAMINASE; ALGORITHMS; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84899441067     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.01.045     Document Type: Article

References (21)

1. H.B. El-Serag, A.B. Siegel, and J.A. Davila et al. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study J Hepatol 44 2006 158 166
2. M. Sherman, J. Bruix, and M. Porayko et al. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations Hepatology 56 2012 793 796
3. J. Bruix, M. Sherman, and J.M. Llovet et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
4. D. Poon, B.O. Anderson, and L.T. Chen et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009 Lancet Oncol 10 2009 1111 1118
5. S. Gupta, S. Bent, and J. Kohlwes Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis Ann Intern Med 139 2003 46 50
6. T.M. Chen, P.T. Huang, and M.H. Tsai et al. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy J Gastroenterol Hepatol 22 2007 669 675
7. A.M. Di Bisceglie, R.K. Sterling, and R.T. Chung et al. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial J Hepatol 43 2005 434 441
8. P. Richardson, Z. Duan, and J. Kramer et al. Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients Clin Gastroenterol Hepatol 10 2012 428 433
9. H.B. El-Serag, and F. Kanwal Alpha-fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it Clin Gastroenterol Hepatol 11 2013 441 443
10. J.A. Davila, A. Weston, and W. Smalley et al. Utilization of screening for hepatocellular carcinoma in the United States J Clin Gastroenterol 41 2007 777 782
11. F.E. Harrell Regression Modeling Strategies 2001 Springer New York
12. M.J. Pencina, R.B. D'Agostino Sr., and R.B. D'Agostino Jr. et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
13. P. McCullagh, and J. Nelder Generalized Linear Models 2nd ed. 1989 Chapman & Hall/CRC Monographs on Statistics & Applied Probability London
14. T. Hastie, R. Tibshirani, and J. Friedman The Elements of Statistical Learning: Data Mining, Inference, and Prediction 2009 Springer New York
15. R. Fan, M. Zhong, and S. Wang et al. Entropy-based information gain approaches to detect and to characterize gene-gene and gene-environment interactions/correlations of complex diseases Genet Epidemiol 35 2011 706 721
16. J.D. Nelson Finding useful questions: on Bayesian diagnosticity, probability, impact, and information gain Psychol Rev 112 2005 979 999
17. Y. Zhao, M.H. Chen, and B. Pei et al. A Bayesian approach to pathway analysis by integrating gene-gene functional directions and microarray data Stat Biosci 4 2012 105 131
18. S.E. Bleeker, H.A. Moll, and E.W. Steyerberg et al. External validation is necessary in prediction research: a clinical example J Clin Epidemiol 56 2003 826 832
19. E. Lee, S. Edward, and A.G. Singal et al. Improving screening for hepatocellular carcinoma by incorporating data on levels of alpha-fetoprotein, over time Clin Gastroenterol Hepatol 11 2013 437 440
20. K.G. Moons, A.P. Kengne, and D.E. Grobbee et al. Risk prediction models: II. External validation, model updating, and impact assessment Heart 98 2012 691 698
21. M.S. Pepe, R. Etzioni, and Z. Feng et al. Phases of biomarker development for early detection of cancer J Natl Cancer Inst 93 2001 1054 1061